Home » Newsletters » BioWorld

BioWorld

Oct. 2, 1992

View Archived Issues

ONCOGENE GETS $3 MILLION GRANT

FDA ALLOWS SERAGEN TO START TRIALS

APPOINTMENTS AND ADVANCEMENTS

TSI GETS LICENSE FROM CELLGENESYS

RAGGIO FIGHTS TERMINATION OF LICENSE PACT

CEPHALON REPORTS SAFETY DATA

CLASS OF '92 FACED A TOUGH MARKET

BIOTECHNICA ACQUIRES FACILITY

ACQUISITION EXPANDS ATS TECHNOLOGY